Zoll Medical Corp. (ZOLL) Tops Q3 EPS by 7c; Guides FY11 EPS Growth
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq hit record highs as Treasury yields stall, oil slips
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mailGet Alerts ZOLL Hot Sheet
Join SI Premium – FREE
Zoll Medical Corp. (NASDAQ: ZOLL) reported Q3 EPS of $0.42, $0.07 better than the analyst estimate of $0.35. Revenue for the quarter came in at $136.2 million versus the consensus estimate of $129.97 million.
Sees FY11 EPS in mi-$1.30's. Consensus sees EPS of $1.27.
Sees FY11 EPS in mi-$1.30's. Consensus sees EPS of $1.27.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lamb Weston (LW) Tops Q1 EPS by 15c ; Offers Guidance
- Zscaler reaffirms fiscal 2027 guidance at investor day
- Integra LifeSciences cuts 2026 outlook after Cincinnati flood
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
